School of Medicine
Showing 781-790 of 954 Results
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
On Leave from 2026-09-01 To 2026-10-31Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Dr. Michael T. Longaker
Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering
Current Research and Scholarly InterestsWe have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.
-
Frank M. Longo, MD, PhD
George E. and Lucy Becker Professor of Medicine and Professor, by courtesy, of Neurosurgery
On Partial Leave from 2026-10-01 To 2027-07-02Current Research and Scholarly InterestsClinical interests include Alzheimer's disease and Huntington's disease and the development of effective therapeutics for these disorders. Laboratory interests encompass the elucidation of signaling mechanisms relevant to neurodegenerative disorders and the development of novel small molecule approaches for the treatment of neurodegenerative and other neurological disorders.
-
Isaac Longobardi
MD Student with Scholarly Concentration in Clinical Research, expected graduation Spring 2030
Stanford Graduate Student Employee, Medicine - Primary Care and Population HealthBioIsaac Longobardi, from Brooklyn, New York, is pursuing an MD at Stanford School of Medicine. He received his bachelor’s degree in social anthropology from Harvard College. Isaac aspires to transform long-term care services and delivery models for individuals with frailty, chronic illness, and mental and behavioral health conditions and their communities. Between 2022 and 2025, Isaac helped to launch and directed the Moving Forward Nursing Home Quality Coalition—a representative group of nursing home stakeholders working to advance recommendations from “The National Imperative to Improve Nursing Home Quality,” a landmark 2022 report by the National Academies of Sciences, Engineering, and Medicine. Prior to that, he piloted multigenerational living while working as a volunteer youth and community engagement program coordinator at Hebrew SeniorLife, a Boston-based elder services nonprofit. Isaac’s speaking and writing on aging and long-term care include award-winning undergraduate research, a Substack, co-authored health policy articles, and conference presentations.
ORCID: https://orcid.org/0009-0009-8481-571X -
James Longoria, MD
Clinical Associate Professor, Cardiothoracic Surgery
BioDr. Longoria is a board-certified, fellowship-trained cardiothoracic surgeon. He is a clinical associate professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
Deeply accomplished in all facets of complex adult cardiothoracic procedures, Dr. Longoria is a high-volume surgeon with more than 20 years of experience and an exceptionally low mortality and complication rate.
Dr. Longoria’s surgical experience includes complex mitral valve and tricuspid valve repair, coronary artery bypass grafting, adult congenital repair, as well as procedures for high risk VAD patients. He performs cardiac transplantation, carotid endarterectomy, and implantation of all FDA-approved mechanical circulatory support devices. Additionally, he performs catheter-based valvular procedures (such as transcatheter aortic valve replacement, or TAVR) and open and video-assisted thoracoscopic surgery (VATS) for pulmonary surgical procedures.
He has an applied interest in atrial fibrillation (AFib) and is a nationally recognized expert in the minimally invasive surgical treatment of Atrial Fibrillation (AFib). Dr. Longoria was issued a method patent from the U.S. Patent and Trademark Office for developing the TTMaze (Totally Thoracoscopic) procedure that is central to the Dual Epicardial Endocardial Persistent (DEEP) AFib clinical trial.
Before joining Stanford, Dr. Longoria was the surgical director of cardiac ablation at a prominent AFib center certified by the Society of Chest Pain Centers. He holds patents for a synthetic chord used to connect tissue and for specialized methods he developed to treat cardiac arrhythmias.
At Stanford, Dr. Longoria brings a commitment to patientcentric, personalized care. He is committed to making the experience of surgery as pleasant as possible for his patients. He is also excited for the opportunity to conduct translational research that utilizes the most advanced technology available, in collaboration with colleagues from other disciplines.
For his outcomes and high patient satisfaction ratings, Dr. Longoria has earned awards and recognition, including being named a Top Doctor of Sacramento by his peers for the last five years in a row. He has also been an honoree of the President’s Award for patient satisfaction by the Sutter Independent Physicians.
Dr. Longoria has published articles on genetic variants associated with atrial fibrillation, thoracoscopic left atrial appendage clipping, radiofrequency ablation, and other topics. His work has appeared in the Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of the American College of Cardiology, Journal of Cardiovascular Electrophysiology, and elsewhere.
He has made numerous presentations on atrial fibrillation surgery and other topics at conferences including the Annual Meeting of the American Association of Thoracic Surgery, Society of Thoracic Surgeons, and International Society for Heart and Lung Transplantation.
Dr. Longoria is a Fellow of the American College of Surgeons and American College of Cardiology. He is a member of the Society of Thoracic Surgeons, Western Thoracic Surgical Association, the International Society for Minimally Invasive Cardiothoracic Surgery, and the Heart Rhythm Society. -
Billy W Loo Jr, MD, PhD, FASTRO, FACR
Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy clinical specialty is precision targeted radiotherapy of thoracic cancers.
My research is on developing next-generation ultra-rapid radiotherapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.
My clinical research is on advanced 4-D image-guided radiotherapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers. -
Kimberly Loo
Clinical Assistant Professor, Medicine - Oncology
BioDr. Kimberly Loo is a Clinical Assistant Professor of Medicine (Oncology) at Stanford University School of Medicine, with a clinical and research focus in melanoma and solid tumor cellular therapy.
Dr. Loo completed her undergraduate studies at the University of California, Los Angeles (UCLA), earned her MD from the Lewis Katz School of Medicine at Temple University, completed her Internal Medicine residency at New York-Presbyterian/Weill Cornell Medicine in collaboration with Memorial Sloan Kettering Cancer Center, and her Hematology and Medical Oncology fellowship and Master of Science in Clinical and Translational Investigation at Weill Cornell Medicine.
Dr. Loo is a clinical investigator specializing in melanoma, immuno-oncology, and solid tumor cellular therapies. Her research focuses on translating discoveries in cancer immunology into more effective immunotherapies and cellular therapies for patients. Dr. Loo has received national recognition for her clinical and translational research, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, and her work has been supported by competitive research funding dedicated to advancing cancer therapies.
